Natural Product: NPC476055

Natural Product IDNPC476055
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Fremontin
IUPAC Name 3-[2,4-dihydroxy-5-(2-methylbut-3-en-2-yl)phenyl]-5,7-dihydroxychromen-4-one
Synonyms Fremontin
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL523643
PubChem CID 5487268
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0002901] Isoflav-2-enes
          • [CHEMONTID:0000494] Isoflavones

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey XWUWFNSZQDCXCD-UHFFFAOYSA-N
Standard InCHI InChI=1S/C20H18O6/c1-4-20(2,3)13-7-11(14(22)8-15(13)23)12-9-26-17-6-10(21)5-16(24)18(17)19(12)25/h4-9,21-24H,1H2,2-3H3
SMILES C=CC(C)(C)c1cc(c2coc3cc(cc(c3c2=O)O)O)c(cc1O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   354.11 Volume:   357.82
?
Van der Waals volume.
Dense:   0.99 LogP:   3.072
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.74
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.725
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   3.0 Rigid Bonds:   19.0
TPSA:   111.13
?
Topological Polar Surface Area.
H-Bond Acceptor:   6.0
H-Bond Donor:   4.0 Rings:   3.0
Heavy Atoms:   6.0

MedChem Properties

QED Drug-Likeness Score:   0.533 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.06 Fsp3:   0.15
MCE-18:   22.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.776 Fluc inhibitor:   0.283
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.829
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.619
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.495 Promiscuous compounds:   0.213

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.134 MDCK Permeability:   -4.847
Pgp-inhibitor:   0.097 Pgp-substrate:   0.037
PAMPA:   0.158
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.932 30% Bioavailability (F30%):   0.999
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.781
Plasma Protein Binding (PPB):   97.655% Volume Distribution (VD):   -0.097
Fu: 2.314%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.998
OATP1B3 inhibitor:   0.997 BCRP inhibitor:   0.999
BSEP inhibitor:   0.554

ADMET: Metabolism

CYP1A2-inhibitor:   0.953 CYP1A2-substrate:   0.954
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.099
CYP2C9-inhibitor:   0.998 CYP2C9-substrate:   0.943
CYP2D6-inhibitor:   0.988 CYP2D6-substrate:   0.997
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.963
CYP2B6-substrate:   0.002 CYP2C8-inhibitor:   1.0
HLM stability:   0.946
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  0.864 Half-life (T1/2):  1.788

ADMET: Toxicity

hERG Blockers:  0.084 hERG Blockers (10um):  0.627
Human Hepatotoxicity (H-HT):  0.333 Drug-induced Liver Injury (DILI):  0.652
AMES Toxicity:  0.437 Rat Oral Acute Toxicity:  0.736
Maximum Recommended Daily Dose:  0.954 Skin Sensitization:  0.594
Carcinogencity:  0.573 Eye Corrosion:  0.043
Eye Irritation:  0.995 Respiratory Toxicity:  0.951
Drug-induced Neurotoxicity:  0.145 Ototoxicity:  0.227
Hematotoxicity:  0.031 Drug-induced Nephrotoxicity:  0.065
Genotoxicity:  0.969 RPMI-8226 Immunitoxicity:  0.111
A549 Cytotoxicity:  0.741 Hek293 Cytotoxicity:  0.836
BCF:   1.458
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.162
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.388
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.863
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO11841 Psorothamnus arborescens Species Fabaceae Eukaryota n.a. root n.a. PMID[16441066]
NPO11841 Psorothamnus arborescens Species Fabaceae Eukaryota root n.a. n.a. PMID[16441066]
NPO2575 Psorothamnus fremontii Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[26469557]
NPO2575 Psorothamnus fremontii Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[2681536]
NPO2575 Psorothamnus fremontii Species Fabaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO11841 Psorothamnus arborescens Species Fabaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO2575 Psorothamnus fremontii Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO11841 Psorothamnus arborescens Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT189 Cell line Vero Chlorocebus aethiops IC50 = 134000.0 nM PMID[24953953]
NPT306 Cell line PC-3 Homo sapiens IC50 = 78500.0 nM DOI[10.6019/CHEMBL1201861]
NPT566 Organism Salmonella typhimurium Salmonella enterica subsp. enterica serovar Typhimurium Inhibition = 93.0 % PMID[10075763]
NPT566 Organism Salmonella typhimurium Salmonella enterica subsp. enterica serovar Typhimurium Inhibition = 24.0 % PMID[26854381]
NPT566 Organism Salmonella typhimurium Salmonella enterica subsp. enterica serovar Typhimurium Inhibition = 0.0 % PMID[18494522]
NPT566 Organism Salmonella typhimurium Salmonella enterica subsp. enterica serovar Typhimurium Inhibition = 65.0 % PMID[18494522]
NPT566 Organism Salmonella typhimurium Salmonella enterica subsp. enterica serovar Typhimurium Inhibition = 87.0 % PMID[19761234]
NPT566 Organism Salmonella typhimurium Salmonella enterica subsp. enterica serovar Typhimurium Inhibition = 81.0 % PMID[12027747]
NPT566 Organism Salmonella typhimurium Salmonella enterica subsp. enterica serovar Typhimurium Inhibition = 90.0 % PMID[11754614]
NPT566 Organism Salmonella typhimurium Salmonella enterica subsp. enterica serovar Typhimurium Inhibition = 58.0 % PMID[11754614]
NPT566 Organism Salmonella typhimurium Salmonella enterica subsp. enterica serovar Typhimurium Inhibition = 92.0 % PMID[15165157]
NPT633 Organism Leishmania donovani Leishmania donovani IC50 = 123000.0 nM PMID[23848163]
NPT471 Organism Trypanosoma brucei brucei Trypanosoma brucei brucei IC50 = 75300.0 nM PMID[19117486]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC476055 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.6769 Remote Similarity NPC485109
0.6207 Remote Similarity NPC87545
0.5821 Remote Similarity NPC232947
0.5781 Remote Similarity NPC279668
0.5692 Remote Similarity NPC45291
0.569 Remote Similarity NPC193792
0.56 Remote Similarity NPC484048
0.5593 Remote Similarity NPC39426
0.5593 Remote Similarity NPC608554
0.5469 Remote Similarity NPC19980
0.5455 Remote Similarity NPC264550
0.5429 Remote Similarity NPC475705
0.5417 Remote Similarity NPC231763
0.541 Remote Similarity NPC38065
0.5397 Remote Similarity NPC78341
0.5385 Remote Similarity NPC309154
0.5362 Remote Similarity NPC213659
0.5362 Remote Similarity NPC326109
0.5312 Remote Similarity NPC294409
0.5312 Remote Similarity NPC490701
0.5294 Remote Similarity NPC93552
0.5231 Remote Similarity NPC239363
0.5217 Remote Similarity NPC238279
0.5205 Remote Similarity NPC303197
0.5152 Remote Similarity NPC200316
0.5143 Remote Similarity NPC85131
0.5075 Remote Similarity NPC278323
0.5075 Remote Similarity NPC194653
0.5075 Remote Similarity NPC481044
0.507 Remote Similarity NPC606200
0.5068 Remote Similarity NPC474052

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC476055 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5593 Remote Similarity NPD1510 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data